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The history of twentieth-century medical drugs is a research subject to 
which many contributions are currently being made from history of science, 
medicine and from history of industry 1. The historiography of antibiotics has 
in good part underlined the role of penicillin as the pioneer miracle since 
its creation in the 1940s. Penicillin became the emblematic wonder-drug of 
the post-WWII years and its discovery, production and distribution have 
been celebrated for half a century as a compelling and relevant historical 
subject. It also seems to indicate a shift in the history of pharmaceutical 
industries, in that this history was presumably dominated by Germany 
until World War II, when the United States took over. The U.S. also stood 
out among the nations whose use and production of penicillin has been 
comprehensively studied 2.
 1. Current development in the history of medical drugs is shown in some recent publications. 
Regarding the history of infections, see Worboys, Michael; Condrau, Flurin, eds. Tuberculosis, 
then and now: interdisciplinary perspectives on a post-modern plague. Montreal: McGill 
University Press; 2010. Quirke, Vivian; Slinn, Judy, eds. Perspectives on twentieth-century 
pharmaceuticals. Oxford: Peter Lang; 2010. Bonah, Christian; Masutti, Christophe; Rasmussen, 
Anne; Simon, Jonathan, eds. Harmonizing drugs: standards in 20th-century pharmaceutical 
history. Paris: Glyphe; 2009. Simon, Jonathan; Gradmann, Christoph, eds. Evaluating and 
standardizing therapeutic agents, 1890-1950 New York: Palgrave Macmillan; 2010. Tone, 
Andrea; Watkins, Elisabeth Siegle, eds. Medicating modern America: prescription drug in 
history. New York: New York University Press; 2007. Bonah, Christian; Rasmussen, Anne, eds. 
Histoire et médicament aux 19e et 20e siècles. Paris: Gliphe; 2005.
 2. Hobby, Gladys. Penicillin. Meeting the challenge. New Haven-London: Yale University Press; 1985. 
MacFarlane, Gwyn. Alexander Fleming, the man and the myth. London: Chatto and Windus; 
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The paper in which Fleming described penicillin and its antimicrobial 
effect was published in 1929 and some exploratory trials followed soon 
after 3. A decade later Howard Florey, Ernst Chain and their colleagues at 
Oxford University developed a therapeutics agent, although in tiny amounts, 
which allowed testing on a few promising cases 4. It was during WWII at 
the Northern Research Laboratory of the US Department of Agriculture in 
Peoria (Illinois) where an efficient method of production was devised. This 
included the addition of corn-steep liquor to the medium and submerged 
culture growth. With the support of its vice-president Alfred Newton 
Richards, the Committee of Medical Research of the Office of Scientific 
Research and Development (OSRD) promoted penicillin production as part 
of the WWII effort in the U.S. From the pilot plant, the production moved 
to manufacturing plants through the involvement of pharmaceutical firms 
such as Merck, Pfizer, Squibb and Lilly. The effectiveness of the treatment 
of infections with penicillin was confirmed in the treatment of wounds and 
surgical infections on the war front, including venereal diseases 5. The rise 
of this medicine was also closely connected to that of standardised proto-
cols of treatment and evaluation such as the randomised controlled trial 
(RCT), the first of which was done in 1947 on the antibiotic streptomycin 6. 
Collaboration between industry, policy-makers and academic scientists 
played its part and worked as a pattern for further drugs developments of 
industrial products from then on 7.
1984. Bud, Robert. Penicillin. Triumph and tragedy. Oxford-New York: Oxford University Press; 
2007. 
 3. Wainwright, Milton; Swan, Harold T. C. G. Paine and the earliest surviving clinical records of 
penicillin therapy. Medical History. 1986; 30: 42-56.
 4. Brown, Kevin. Penicillin man: Alexander Fleming and the antibiotic revolution. Gloucestershire: 
Sutton; 2004. On early penicillin trials, Wainwright and Swan, n. 3.
 5. Hobby, n. 2, and also the contributions to Parascandola, John, ed. The history of antibiotics: a 
simposium. Madison: American Institute of the History of Pharmacy; 1980. See also Marks, 
Harry. The progress of experiment: science and therapeutic reform in the United States, 1900-
1990. Cambridge: Cambridge University Press; 1997; Weatherall, Mark. In search of a cure. 
A history of pharmaceutical discovery. Oxford: Oxford University Press; 1990; Parascandola, 
John. John Mahoney and the introduction of penicillin to treat syphilis. Pharmacy in History. 
43; 2001: 3-13.
 6. Marks, n. 5; 1997; Podolsky, Scott H. Antibiotics and the social history of the controlled clinical 
trial. Journal for the History of Medicine and Allied Sciences. 2010; 65: 327-367. 
 7. Swann, John P. Academic scientists and the pharmaceutical industry: cooperative research in 
twentieth century America. Baltimore: Johns Hopkins University Press; 1988. Quirke, Viviane. 
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The pioneering book by Gladys Hobby has told many important details 
on the history of penicillin. Later, others emerged to complete the penicillin 
landscape by connecting it with national policies —histories of success 
and antibiotic resistance— and by challenging the heroic perception of the 
discovery 8. The powerful image of the drug as a hero has been softened 
however by more recent studies that situate the success and the tragedy, as 
Bud dramatically put it, of penicillin in a cultural world extremely sensitive 
to health, wealth and authority 9.
Many contributions to what could have been perceived as small details 
exhibit timescapes of practices and distribution of a group of drugs that 
changed our perception of disease and therapy by creating an image of the 
likeliness of infections disappearing altogether —brought about by antibiotics 
and vaccines 10. In parallel to the seemingly miraculous effects of penicillin 
came the rise of antimicrobial resistances as a clinical phenomenon 11. So-
me microbes were not sensitive to such medicines in the first place, while 
those that were developed resistant strains, thus leading to the search for 
new antibiotics, and challenging the hygienic regimes in hospital wards 12.
After the impact of the Second World War on the production of drugs 
and on the pharmaceutical industry, the post-war period saw a political 
environment in which infections and the fight against them kept war alive: 
the war against diseases involved a wide range of actions and agents of 
Collaboration in the pharmaceutical industry: changing relationships in Britain and France. 
Abingdon-New York: Routledge; 2008.
 8. Bud, n. 2; Lesch, John E. The first miracle drugs: how the sulfa drugs transformed medicine. 
Oxford: Oxford University Press; 2007; Greenwood, David. Antimicrobial drugs. Chronicle of a 
twentieth-century triumph. Oxford: Oxford University Press; 2008, can serve as introductions. 
 9. Bud, n. 2.
 10. On penicillin shortages of its early days, see Adam, David P. «The greatest good to the greatest 
number». Penicillin rationing on the American home front, 1940-1945. New York-Bern: Peter 
Lang; 1991. 
 11. For an introduction see Summers, William C. Microbial drug resistance: a historical perspective. 
In: Wax, Richard G.; Lewis, Kim; Salyers, Abigail A.; Taber, Harry, eds. Bacterial resistance to 
antimicrobials. Boca Raton: CRC Press; 2008, p. 1-9; Tansey, E. M.; Reynolds, L. A., eds. Welcome 
witness seminar. Volume 6. Post-penicillin antibiotics. From acceptance to resistance? London: 
The Welcome Trust; 2000. At http://www.ucl.ac.uk/silva/histmed/downloads/c20th_group/
wit6.pdf. See also Creager, Angela N. H. Adaptation or selection? Old issues and new stakes 
on the post-war debates over bacterial drug resistance. Studies in History and Philosophy 
of Biological and Biomedical Sciences. 2007; 38: 159-190; and Gradmann in this issue.
 12. Hillier, Kathryn. Babies and bacteria: phage typing, bacteriologists, and the birth of infection 
control. Bulletin of the History of Medicine. 2006; 80: 733-761; and Condrau/Kirk in this issue.
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different levels of recognition and responsibilities. In addition, narratives 
of medicalisation and medication, of health and disease, of health as a right 
emerged as part of public policies and international strategies that were 
rising to prominence 13.
As Quirke and Slinn put it, «geopolitical events, in particular two 
World Wars, regulatory changes, especially in the U.S. and key develop-
ments and discoveries, such as those of diphtheria antiserum, antibiotics 
and more recently the development of biotechnology have created major 
discontinuities» in the history of 20th century pharmaceuticals 14. Instead 
of a revolution produced by a miracle, the history of antibiotics provoked 
«changes that occurred over a long period, and while there were significant 
shifts in ideas and practices […], the balance of continuities and changes 
was quite uneven across medicine», as Worboys has said on the so-called 
bacteriological revolution 15. The eventual outcome was also rather an unex-
pected one. Infectious disease, which many in the after-war years thought 
would cease to be of relevance, was in fact re-invented instead. The return of 
such conditions was put in the phrase of the «antibiotic paradox» by Stuart 
Levy, thereby framing a historical situation in which «antibiotic usage has 
stimulated evolutionary changes that are unparalleled in biologic history» 16.
The growing authority of the laboratory and of the clinical sciences is 
among the arguments which should be taken into account when trying to 
 13. Quirke, Viviane. War and change in the pharmaceutical industry: a comparative study of Britain 
and France in the twentieth century. Enterprises et Histoire. 2004; 36: 64-83. On the war against 
diseases see the case of polio in Smith, Jane S. Patenting the sun: polio and the Salk vaccine. 
New York: Anchor Books; 1990; Creager, Angela N. H. The war against polio. In: The life of 
a virus: tobacco mosaic virus as an experimental model, 1930–1965. Chicago: University of 
Chicago Press; 2002, p. 141–184. On primary care as an international agreement promoted 
by the World Health Organisation, see Health for all beyond 2000. Declaration of Alma-Ata. 
International Conference on Primary Health Care, Alma-Ata, USSR, 6-12 September 1978. At 
http://www.who.int/hpr/NPH/docs/declaration_almaata.pdf. On the declaration see Navarro, 
Vicente. A critique of the ideological and political positions of the Willy Brandt report and 
the WHO Alma Ata declaration. Social Science and Medicine. 1984; 18: 467-474. 
 14. Quirke, Viviane; Slinn, Judy. Perspective in twentieth-century pharmaceuticals: an introduction. 
In: Quirke and Slinn, n. 1, p. 1-34 (7).
 15. Worboys, Michael. Was there a bacteriological revolution in late nineteenth-century medicine? 
Studies in History and Philosophy of Biological and Biomedical Sciences. 2007; 38: 20-42; 
MacFarlane, John T.; Worboys, Michael. The changing management of acute bronchitis in 
Britain, 1940-1970: the impact of antibiotics. Medical History. 2007; 52: 47-72.
 16. Levy, Stuart B. The antibiotic paradox. How miracle drugs are destroying the miracle. New 
York-London: Plenum Press; 1992; Bourdelais, Patrice. Epidemics laid low: a history of what 
happened in rich countries. Baltimore: Johns Hopkins University Press; 2006 (2003).
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explain historically the declining impact of infections, the success of anti-
biotics in their treatment, resistances to their action, and the whole set of 
institutional changes associated with antibiotics practices. In this regard, 
the image of Fleming looking through the microscope as a scientific image 
of the discovery and the discoverer of penicillin is remarkable and remained 
part of post-war imagery 17.
The central role played by science as expert knowledge in contempo-
rary societies and by its related practices in civil life and governance, kept 
drugs, and particularly antibiotics, either miraculous or not, at the core of 
public scrutiny.
More recent studies of penicillin experiences have shown, however, that 
there was not a standard trajectory of penicillin. Every nation, every factory, 
every microbial species attacked added to a wide, growing set of histories 
about penicillin. Even the standard melancholic historical reconstruction 
of penicillin in Britain, where it was produced as a drug, identified and 
tested —only to later be mass-produced by the U.S.— has been revised 18. In 
the Netherlands, as Marlene Burns has shown, during the Nazi occupation 
an antibiotic named bacinol was clandestinely produced by microbiologist 
Albert Jan Kluyver at a research laboratory in Delft. In France, trips to the 
U.S. and back made French production of penicillin possible. In Germany, 
pharmaceutical companies like Bayer, who had pioneered the sulfa drugs, 
struggled to catch up with international developments in relation to fun-
gal antibiotics. Meanwhile, U.S. firms were selling penicillin abroad and, 
later, royalties paid to those firms made production of the drug in other 
countries possible 19. 
 17. Chen, Wai. The laboratory as business. Sir Almroth Wright’s vaccines programme and the con-
struction of penicillin. In: Cunningham, Andrew; Williams, Perry, eds. The laboratory revolution 
in medicine. Cambridge: Cambridge University Press; 1992, p. 245-292.
 18. Liebenau, Jonathan. The British success with penicillin. Social Studies of Science. 1987; 17: 69-
86.
 19. Burns, Marlene. Scientific research in the Second World War. The case for Bacinol, Dutch penicil-
lin. In: Maas, Ad; Hooijmaijers, Hans, eds. Scientific research in World War II. What scientists 
did in the war? London-NewYork: Routledge; 2009, p. 44-61; Bartmann, Wilhelm. Zwischen 
Tradition und Fortschritt. Aus der Geschichte der Pharmabereiche von Bayer, Hoechst und 
Schering von 1935-1975. Stuttgart: Steiner; 2003; Shama, Gilbert; Reinarz, Jonathan. Allied 
intelligence reports on wartime German penicillin research and production. Historical Studies 
on the Physical and Biological Sciences. 2002; 32: 347-367. On France, see Gaudillière, Jean-
Paul. Inventer la biomedicine: la France, l’Amerique et la production des savoirs du vivant. 
Paris: La Découverte; 2002, chapter 1; Gaudilliere, Jean-Paul; Gausemeier, Bern. Moulding 
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And, of course, there are historiographies of many other anti-infective 
agents waiting to be explored. This dossier aims at contributing to fill some 
of the gaps in the history of antibiotics.
Circulation
All these national histories from the post-war period remind us that despite 
the internationalism of the drug market and its underlying science, drugs 
continued to be handled within national frameworks. While standardisa-
tion and internationalisation were part and parcel of the evaluation and 
production of antibiotics, the view on the circulation of such medicine 
serves to highlight the national policies involved in the post-WWII era. 
These policies shaped early production of penicillin in the laboratory, at 
the bench of modest research settings as well as in the factory 20.
National politics and policies notwithstanding, penicillin as an object 
was transnational through travelling. News of its therapeutic capabilities 
against infections travelled first —in publications and mouth to mouth. 
The drug itself, in its ampoules in boxes, travelled along with protocols of 
its use. The doses and types of infections that could be successfully treated 
also circulated, as did methods of industrial manufacturing.
As a piece of technology bred in laboratories, antibiotics were one of 
the most important ingredients for the new gods of welfare, peoples’ and 
nations’ wealth and health —and for the technological optimism of the age 
that found one of its personifications in pills designed to control disease 
and enhance life 21. A recently published history of sulfa-drugs shows a 
complex landscape of practices from chemistry laboratories to the factory, 
from dyes to therapy, transitions which suggest the circulation of knowledge 
and practices that featured contemporary cultures 22. 
The idea of circulation is introduced here to elaborate on the travels 
involved in knowledge production. As knowledge whose practices have 
national research systems: the introduction of penicillin to Germany and France. Osiris. 2005; 
20: 180-202. On Spain, see Santesmases, María Jesús. Delivering penicillin: the clinic, the hero 
and industrial production in Spain, 1943-1952. In: Quirke, Vivian; Slinn, Judy, eds. Perspectives 
on twentieth-century pharmaceuticals. Oxford: Peter Lang; 2010, p. 91-117.
 20. Gaudillière, 2002, n. 19, chapter 1.
 21. Bud, n. 2, p. 97-115.
 22. Lesch, n. 8.
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been, and still are, in search of reproduction and verification, the permanent 
adjustment of laboratory and factory practices of drugs production was 
linked to travels to and from different geographical places and professional 
domains, and to bodies and times of antibiotics 23.
Some of these trajectories were physical ones: batches of antibiotics 
travelled, protocols and instructions of use and production were distributed 
and received in particular local settings, promoted by national authorities. 
By suggesting the concept of circulation, we would like to draw attention to 
the issue of standards themselves embarking on such journeys. The papers 
included in this dossier explore the trajectories of antibiotics standards re-
garding its production, microbiological practices, clinical standards, patents 
as regulators, and research practices. As a set, the dossier contributes to the 
study of how activities involved in producing and using antibiotics influen-
ced each other and eventually shaped public health and epidemiology 24. 
Bacterial resistances to antibiotics contributed to shaping research and 
medical practices. In that way, the phenomenon contributed to an increasing 
knowledge about the mechanisms of antibiotics action at the cellular level, 
and also provided the basis upon which further search for new antibio-
tics developed. Penicillin was the first of a long series of antibiotic drugs: 
streptomycin’s successful effect in the treatment of tuberculosis followed, 
as did chloramphenicol and tetracyclines. Figures of treatment results, of 
cure and resistances, travelled as well, and public health and epidemiology 
became part of the issue 25.
Embedded in every ampoule, flask, coated-pill, were the practices of 
producing, distributing and using the substance. Antibiotics linked prac-
tices in different social and cultural domains, and within them standards 
moved around from chemistry laboratories to fermentation pilot plants. 
Clinicians, researchers, patients and health authorities as well as fiction and 
non-fiction recollections would shape antibiotics cultures 26.
 23. Gaudillière, Jean-Paul; Hess, Volker, eds. Ways of regulating: therapeutic agents between plants, 
shops and consulting rooms. Berlin: Max Planck Institut für Wissenschaftsgeschichte; 2009. 
 24. Macfarlane; Worboys, n. 15 
 25. Weatherall, n. 3.
 26. Regarding non-fiction, see the history of Hitler taking penicillin during WWII. Wainwright, M. 
Hitler’s penicillin. Perspectives in Biology and Medicine. 2004; 47: 189-198. On fiction, the 
best known may be Carol Reed’s, The third man (1949), based on the novel of the same title 
by Graham Green. A Spanish film was also produced on the same issue: Mercado prohibido 
(1952), by Xavier Setó. 
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The image of the U.S. Army delivering penicillin after the war is a 
powerful one, just as there are many others regarding success, failures, 
public opinion, local settings, moral economies, marketing and labelling, 
brand policies. Antibiotics’ power and images did not come to be spread 
from a single source. Some of the individuals and collectives who became 
agents in antibiotics history are part of this dossier.
American penicillin manufacturing success was part of the dramatic 
development of biomedical sciences in that country, of the intense history of 
research practices and policy-making that established global scientific and 
industrial leadership during the Cold War years. Regulation of the prescription 
of new drugs was part of the history, connected to the emergence of welfare 
state policies in some European countries and to insurance policies in the 
U.S. 27. Agents, however, acted locally. Beyond trends toward globalisation 
and toward any apparent homogenisation through standardisation, nations 
remain relevant for historical narratives regarding the history of antibiotics.
The contributions to this dossier
 From an earlier collaborative project on drug trajectories made by his-
torians of medicine and science, a European network program, DRUGS, 
was approved by the European Science Foundation in 2007 with the aim 
of developing a history of drugs standards in the 20th century. Such stan-
dards were understood as dynamic structures that are a typical feature of 
the history of the 20th century 28.
This dossier includes a selection of papers presented at the workshop 
«Circulation of Antibiotics: Journeys of drugs standards», held in Madrid in 
June 2008 as part of ESF DRUGS Networking Program 29. Each contribution 
provides its particular narrative that links the history of antibiotics with 
national politics, with that of infections and resistances of such infections. 
These articles also situate in places and times the microbiological practi-
 27. Tone; Watkins, n. 1. Daemmrich, Arthur. Pharmacopolitics: drug regulation in the United 
States and Germany. Chapel Hill-London: University of Carolina Press; 2004.
 28. Bonah, Christian; Gaudillière; Jean-Paul; Gradmann, Christoph; Hess, Volker. Standard drugs and 
drug standards. A comparative historical study of pharmaceuticals in the 20th century. In: 
Bonah; Masutti; Rasmussen; Simon, eds., n. 1 p. 17-27.
 29. The set of papers presented at the workshop was uploaded at http://drughistory.eu/down-
loads/Madrid_Preprint.pdf
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ces which were at the origins of industrial manufacturing of penicillin by 
fermentation. 
Resistance is reviewed by Christoph Gradmann as a concept that would 
remain central from Paul Erhlich’s works and colonial medical practices for 
tropical infections up to the present. Since, however, resistance as a concern 
for clinical medicine only became relevant during the Second World War, 
its history followed other trajectories after Ehrlich’s observation of the phe-
nomenon in 1907. As Gradmann shows, induced resistance was employed 
as a laboratory tool in cell biology, experimental pharmacology and genetics 
long before it came to be of interest in clinical medicine. Offering evidence 
for the existence of so-called chemoreceptors, it was firmly connected to 
Ehrlich’s side chain theory of immunity.
The roots of penicillin production are revisited by Robert Bud in his 
contribution about chemistry and fermentation chemists who invented 
the practices that led to culturing and isolating the drug. Fermentation 
and microbiology remained instrumental in antibiotics manufacturing and 
laboratory research 30. Fermentation was the kind of process —biological 
and chemical— that formed the practices of antibiotics production. Two 
circumstances, that the works of Bud’s craftsmen had mainly commercial 
purposes and one of the leading chemists was a member of the Nazi par-
ty, explain the apparent invisibility of fermentation skills in the industrial 
construction of penicillin. From chemistry and microbiology to biotechno-
logy, this trajectory may well be the pattern of development of antibiotics 
production, a combination of knowledge and practices of two disciplines 
that joined efforts in twentieth-century drugs development. In this process 
disciplines, their practices and cultures, did matter.
Penicillin was indeed a cultural and political agent of its time. Knowledge 
about this drug and the medical and industrial practices associated with 
it shaped the post-WWII era, involving research, diplomatic and political 
agendas with the aim of producing penicillin to cure infections. This is the 
case of Italy told by Mauro Capocci. One of the first experts in the drug, 
Ernst Chain, moved from Oxford to Rome to promote a project for manu-
facturing penicillin funded by the Italian state. The integration of Italy in the 
international environment of post-WWII Allied politics while promoting 
national industry —practices that evoke the Spanish policies of the Franco 
 30. Bud, n. 2.
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dictatorship after WWII, in particular regarding penicillin— featured the 
introduction of penicillin manufacturing in Italy, where many actors played 
a part in the penicillin research network with the aim of making Rome one 
of the nodes of such a network 31.
Patents not only protected invention rights but also provided details 
of the technical methods for penicillin manufacturing, thus acting as a 
guarantee of productivity and reproducibility as well as mediators between 
different professional domains. As the contribution by Ana Romero shows, 
the history of antibiotics intersected with the history of patenting and in-
dustrial regulation. The documents studied in Romero’s article show the 
journeys of penicillin, the paths taken in those travels, and how the new 
drug spread worldwide after the Second World War, and particularly in 
Spain, precisely by circulating the methods for its industrial manufacturing.
Hospital infections are presented as an agent in the history of clinical 
practices and chemotherapy in Britain by Flurin Condrau and Robert Kirk. 
Hospital infections and antibiotic-resistant bacteria were redefined by the 
interplays of differing interests of bacteriologists and clinicians. Antibiotics 
were part of an «arsenal» for medical success, while the clinic witnessed 
and reacted to a context of ever-adapting hospital infections during the 
emergence of the National Health Service’s claims to provide effective 
healthcare to the population. Condrau and Kirk situate antibiotic resistances 
in the middle of the promising origins of the welfare state, where health 
care was one of the articulators of policy-making in Britain.
The production of antibiotics involved the factory and the laboratory. 
When a screening program was set up in Madrid in 1954, as a collaboration 
of Merck and CEPA (a Spanish firm that was manufacturing penicillin in 
Spain), the resulting research program was organised like industrial manu-
facturing. Santesmases shows how both the factory system of production —a 
production line of craftsmanship to obtain new anti-infectious substances 
from soil samples— and Selman Waksman’s program of research on new 
antibiotics, which successfully led to isolating streptomycin, interacted 
and interchanged practices. Microbiological material and methods were 
agents of both research and industrial manufacturing, thus reinforcing the 
strong connections in practices as well as conceptually between industrial 
manufacturing and research practices. Antibiotics thus became a set of 
 31. Santesmases, n. 19.
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substances which contributed to research not only in the treatment of 
infections and the drug industry, but in microbiological research as well.
History of antibiotic standards shows co-production of standards and 
markets, of products and production processes, of therapeutic specificity, 
of protocols. At the same time, such standards have been local products 
in particular moments of twentieth-century history. And often such stan-
dards remain national or sectorial, significant for a professional domain. 
This suggests that permanent feedback took place between agents and 
professional spaces involved in the history of antibiotics. Not only drugs 
circulated but a diversity of standards did so as well, and contributed to 
the rearrangement of antibiotic cultures and practices.
Early knowledge and practices played their role as a sort of original 
reference, as a guide to manage the new product, to prescribe it and to 
manufacture it, to search for new ones. It needs to be emphasised that a 
question remains open, namely to what extent this early reference —penicillin 
at the end of WWII— carried standards in itself or if it became the sample 
from which standards were developed. As knowledge about successful the-
rapies arrived before the industrially-produced penicillin itself, references 
and standards contributed to homogenisation, which means possibilities to 
replicate, to reproduce results and production. By circulating, by moving 
around and crossing national and professional boundaries, antibiotics, its 
effects and its standards were permanently reconstructed. 

